The post Catherine Dargan On Building Billion-Dollar Deals appeared on BitcoinEthereumNews.com. Illustration by MICHELLE ROHN FOR FORBES Catherine Dargan Firm: Covington Title: Partner Forbes List: America’s Top M&A Lawyers 2025 As global chair of Covington’s Corporate Practice and head of the M&A team, Catherine Dargan has overseen work that spans multibillion-dollar mergers, cross-border acquisitions and complex carve-outs for some of the world’s largest and most sophisticated companies. Dargan began her career at the firm’s DC headquarters, where Covington’s deep regulatory bench provided a natural edge for a life-sciences niche. She steadily built a portfolio that evolved into one of the premier M&A practices, with clients like Merck, Bristol Myers, AbbVie, Gilead and Novartis. Over 25 years of practice, Dargan expanded her cross-industry expertise, carving a spot in the upper echelons of an elite field by leading blockbuster deals, including Novartis’ recent $12 billion acquisition of Avidity Biosciences, Inc. She works with clients in a wide range of business categories—from technology to manufacturing to gaming. And she has grown her considerable book of business by being nimble, knowledgeable and indispensable, qualities that also helped land her on Forbes’ first-ever Top M&A Lawyers List. “I wake up every day thinking about how to solve problems and how to execute more efficiently, how to anticipate the next big obstacle and plan for an actionable solution,” Dargan says. “Doing a deal requires creativity and resourcefulness—it’s like putting together a puzzle. It’s also about building relationships and doing the very best work you can on every single deal.” Dargan expects M&A work to remain brisk, despite external challenges like geopolitical instability, tariffs and the government shutdown. She says there’s tight competition for innovative products in the medical, technology and AI space that companies want to acquire and pipeline—before a competitor does. And for corporations vetting megadeals in an unpredictable economic climate, Dargan considers it her job… The post Catherine Dargan On Building Billion-Dollar Deals appeared on BitcoinEthereumNews.com. Illustration by MICHELLE ROHN FOR FORBES Catherine Dargan Firm: Covington Title: Partner Forbes List: America’s Top M&A Lawyers 2025 As global chair of Covington’s Corporate Practice and head of the M&A team, Catherine Dargan has overseen work that spans multibillion-dollar mergers, cross-border acquisitions and complex carve-outs for some of the world’s largest and most sophisticated companies. Dargan began her career at the firm’s DC headquarters, where Covington’s deep regulatory bench provided a natural edge for a life-sciences niche. She steadily built a portfolio that evolved into one of the premier M&A practices, with clients like Merck, Bristol Myers, AbbVie, Gilead and Novartis. Over 25 years of practice, Dargan expanded her cross-industry expertise, carving a spot in the upper echelons of an elite field by leading blockbuster deals, including Novartis’ recent $12 billion acquisition of Avidity Biosciences, Inc. She works with clients in a wide range of business categories—from technology to manufacturing to gaming. And she has grown her considerable book of business by being nimble, knowledgeable and indispensable, qualities that also helped land her on Forbes’ first-ever Top M&A Lawyers List. “I wake up every day thinking about how to solve problems and how to execute more efficiently, how to anticipate the next big obstacle and plan for an actionable solution,” Dargan says. “Doing a deal requires creativity and resourcefulness—it’s like putting together a puzzle. It’s also about building relationships and doing the very best work you can on every single deal.” Dargan expects M&A work to remain brisk, despite external challenges like geopolitical instability, tariffs and the government shutdown. She says there’s tight competition for innovative products in the medical, technology and AI space that companies want to acquire and pipeline—before a competitor does. And for corporations vetting megadeals in an unpredictable economic climate, Dargan considers it her job…

Catherine Dargan On Building Billion-Dollar Deals

2025/11/05 02:50
3 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

Illustration by MICHELLE ROHN FOR FORBES

Catherine Dargan

Firm: Covington

Title: Partner

Forbes List: America’s Top M&A Lawyers 2025

As global chair of Covington’s Corporate Practice and head of the M&A team, Catherine Dargan has overseen work that spans multibillion-dollar mergers, cross-border acquisitions and complex carve-outs for some of the world’s largest and most sophisticated companies.

Dargan began her career at the firm’s DC headquarters, where Covington’s deep regulatory bench provided a natural edge for a life-sciences niche. She steadily built a portfolio that evolved into one of the premier M&A practices, with clients like Merck, Bristol Myers, AbbVie, Gilead and Novartis. Over 25 years of practice, Dargan expanded her cross-industry expertise, carving a spot in the upper echelons of an elite field by leading blockbuster deals, including Novartis’ recent $12 billion acquisition of Avidity Biosciences, Inc. She works with clients in a wide range of business categories—from technology to manufacturing to gaming. And she has grown her considerable book of business by being nimble, knowledgeable and indispensable, qualities that also helped land her on Forbes’ first-ever Top M&A Lawyers List.

“I wake up every day thinking about how to solve problems and how to execute more efficiently, how to anticipate the next big obstacle and plan for an actionable solution,” Dargan says. “Doing a deal requires creativity and resourcefulness—it’s like putting together a puzzle. It’s also about building relationships and doing the very best work you can on every single deal.”

Dargan expects M&A work to remain brisk, despite external challenges like geopolitical instability, tariffs and the government shutdown. She says there’s tight competition for innovative products in the medical, technology and AI space that companies want to acquire and pipeline—before a competitor does. And for corporations vetting megadeals in an unpredictable economic climate, Dargan considers it her job to be a trusted advisor as well as legal counsel. She gives credit to colleagues and a firm she says puts a premium on collaboration.

“We want to make sure to have the right expertise at our fingertips,” Dargan says. “We’re trying to help [clients] assess the risks so they can continue to do what they do in an uncertain world. It’s part of our role.”

One of the most rewarding parts of her job? Working with innovative clients, many of whom are trying to solve some of the world’s most complex problems: “It’s a great field. And I feel incredibly fortunate to enjoy what I do.”

For the full list of America’s Top M&A Lawyers, click here.

Source: https://www.forbes.com/sites/lianejackson/2025/11/04/purpose-in-the-pressure-catherine-dargan/

Opportunità di mercato
Logo TOP Network
Valore TOP Network (TOP)
$0.0000699
$0.0000699$0.0000699
0.00%
USD
Grafico dei prezzi in tempo reale di TOP Network (TOP)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.